2'-(Benzo[d]oxazol-2-ylamino)-7',7'-dimethyl-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one

Catalog No. :
ACXNOD684
CAS No. :
708289-39-8
Molecular Formula :
C21H24N4O2
Molecular Weight :
364.45

IUPAC Name:2'-(benzo[d]oxazol-2-ylamino)-7',7'-dimethyl-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one

2'-(Benzo[d]oxazol-2-ylamino)-7',7'-dimethyl-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2'-(Benzo[d]oxazol-2-ylamino)-7',7'-dimethyl-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one
IUPAC Name2'-(benzo[d]oxazol-2-ylamino)-7',7'-dimethyl-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one
Molecular FormulaC21H24N4O2
Molecular Weight364.45
SMILESO=C1C(C23CCCC2)=C(NC(NC4=NC5=CC=CC=C5O4)=N3)CC(C)(C)C1
InChI KeyHSVUZCYBPFVTKE-UHFFFAOYSA-N
Synonym2'-(1,3-benzoxazol-2-ylamino)-7',7'-dimethyl-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one;Spiro[cyclopentane-1,4'(3'H)-quinazolin]-5'(6'H)-one, 2'-(2-benzoxazolylamino)-7',8'-dihydro-7',7'-dimethyl-
CAS No.708289-39-8

Synthetic Route by SureRoute

1. ACXNOD684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGNYR408 route compound structure diagram
    ACGNYR408615-18-9 In Stock
  4. Then
  5. ACXNOD684 route product structure diagram
    ACXNOD684708289-39-8
Inquiry

2. ACXNOD684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRXUW367 route compound structure diagram
    ACRXUW3674570-41-6 In Stock
  4. Then
  5. ACXNOD684 route product structure diagram
    ACXNOD684708289-39-8
Inquiry

Comments (0)